Nuvation Bio (NUVB) Retained Earnings (2020 - 2026)
Nuvation Bio (NUVB) posted quarterly Retained Earnings of -$1.1 billion for Q1 2026, down 203769.72% year-over-year from N/an in Q1 2025, and little changed quarter-over-quarter from -$1.1 billion in Q4 2025.
Nuvation Bio (NUVB) Retained Earnings (2020 - 2026) Analysis & Trends
Nuvation Bio (NUVB) has reported Retained Earnings for 7 consecutive years, with -$1.1 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Retained Earnings fell 203769.72% year-over-year to -$1.1 billion; the TTM figure through Mar 2026 stood at -$1.1 billion (down 203769.72% YoY), while the FY2025 annual figure was -$1.1 billion, down 194754.45% from the prior year.
- Retained Earnings was little changed at -$1.1 billion in Q1 2026 per NUVB's latest filing, from -$1.1 billion in the prior quarter.
- Across five years, Retained Earnings topped out at $1.4 million in Q3 2024 and bottomed at -$1.1 billion in Q4 2025.
- Historically, Retained Earnings has averaged -$256.7 million across 5 years, with a median of -$4.4 million in 2023.
- Annual changes were most pronounced in 2024 — Retained Earnings soared 216.57% — and 2026, when it slumped 203769.72%.
- Nuvation Bio's Retained Earnings stood at -$5.5 million in 2022, then surged by 103.28% to $181000.0 in 2023, then jumped by 216.57% to $573000.0 in 2024, then sank by 194754.45% to -$1.1 billion in 2025, then advanced by 0.48% to -$1.1 billion in 2026.
- Business Quant data shows NUVB's Retained Earnings at -$1.1 billion in Q1 2026, -$1.1 billion in Q4 2025, and -$1.1 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Nuvation Bio | 2.16 Bn | 2.16 Bn | 30.78 Mn | -1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.17 Bn |
| Mar 31, 2026 | -1.11 Bn |
| Dec 31, 2025 | -1.12 Bn |
| Sep 30, 2025 | -1.08 Bn |
| Jun 30, 2025 | -1.02 Bn |
| Mar 31, 2025 | 545,000.00 |
| Dec 31, 2024 | 573,000.00 |
| Sep 30, 2024 | 1.38 Mn |
| Jun 30, 2024 | -1.27 Mn |
| Mar 31, 2024 | -1.17 Mn |
| Dec 31, 2023 | 181,000.00 |
| Sep 30, 2023 | -3.30 Mn |
| Jun 30, 2023 | -4.40 Mn |
| Mar 31, 2023 | -2.94 Mn |
| Dec 31, 2022 | -5.53 Mn |
| Sep 30, 2022 | -8.12 Mn |
| Jun 30, 2022 | -6.98 Mn |
| Mar 31, 2022 | -6.22 Mn |
| Dec 31, 2021 | -1.19 Mn |
| Sep 30, 2021 | 388,000.00 |